Pharmacogenomic considerations in opioid analgesia
Pascal H Vuilleumier,1 Ulrike M Stamer,1 Ruth Landau21Klinik für Anästhesiologie und Schmerztherapie, Inselspital Universität Bern, Switzerland; 2Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA, USAAbstract: Translat...
Saved in:
Main Authors: | Vuilleumier PH (Author), Stamer UM (Author), Landau R (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2012-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenomic considerations in opioid analgesia. [Corrigendum]
by: Vuilleumier PH, et al.
Published: (2013) -
Landmarks of pharmacogenomics and some considerations for clinical practice
by: David Nana Ampong
Published: (2019) -
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
by: Alok K. Paul, et al.
Published: (2021) -
Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
by: Cazzola M, et al.
Published: (2020) -
COVID-19: Considerations for obstetric anesthesia and analgesia
by: Venkata Ganesh, et al.
Published: (2020)